P334: Does the circadian clock have a role in the pathogenesis of inflammatory bowel disease (IBD)?ECCO '18 Vienna
2018
P336: Is endoscopy necessary to measure disease activity in ulcerative colitis: A systematic narrative reviewECCO '18 Vienna
2018
P337: Low seroprevalence of celiac disease in a large screening study in unselected Swiss IBD cohort patientsECCO '18 Vienna
2018
P338: Outcome of hospitalised patients with inflammatory bowel disease complicated by Clostridium difficile infection: Results from a tertiary referral centreECCO '18 Vienna
2018
P339: Crohn’s disease and self-monitoring through a mobile App: The Medicrohn studyECCO '18 Vienna
2018
P341: Faecal biomarkers compared with MRI using the MaRIA and Clermont scores for monitoring inflammatory activity in patients with Crohn’s diseaseECCO '18 Vienna
2018
P342: Development of self-screening tool for perianal disease in patients with Crohn’s disease: A pilot studyECCO '18 Vienna
2018
P347: Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAIDECCO '18 Vienna
2018
P348: 3D reconstructions in complex fistulising perianal Crohn’s disease to aid decision-makingECCO '18 Vienna
2018
P349: Deep enteroscopy with a through-the-scope ballon catheter system in paediatric patients with IBDECCO '18 Vienna
2018
P350: Conventional biomarkers in newly diagnosed Crohn’s disease patients may predict early disease progressionECCO '18 Vienna
2018
P351: Bowel ultrasound is accurate in assessing disease activity in ulcerative colitisECCO '18 Vienna
2018